1st Quarter - Report
ERVIN GRAVES STRATEGY GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Disaster Planning/Emergencies DIS
"Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield State opioid response (SOR) Grant funding NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone "
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES L ERVIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.